Lawrie AS, Kitchen S, Efthymiou M, Mackie IJ, Machin SJ. Determination of APTT factor sensitivity—the misguiding guideline. Int J Lab Hematol. 2013;35(6):652–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Favaloro EJ, Kershaw G, Mohammed S, Lippi G. How to optimize activated partial thromboplastin time (APTT) testing: solutions to establishing and verifying normal reference intervals and assessing APTT reagents for sensitivity to heparin, lupus anticoagulant, and clotting factors. Semin Thromb Hemost. 2019;45(1):22–35.

Article  CAS  PubMed  Google Scholar 

Kershaw G, Favaloro EJ. Laboratory identification of factor inhibitors: an update. Pathology. 2012;44(4):293–302.

Article  CAS  PubMed  Google Scholar 

Favaloro EJ, Bonar R, Duncan E, Earl G, Low J, Aboud M, et al. Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation. Thromb Haemost. 2006;96(1):73–8.

CAS  PubMed  Google Scholar 

Kershaw G. Detection and measurement of factor inhibitors. Methods Mol Biol. 2017;1646:295–304.

Article  CAS  PubMed  Google Scholar 

Sborov DW, Rodgers GM. Acquired hemophilia a: a current review of autoantibody disease. Clin Adv Hematol Oncol. 2012;10(1):19–27.

PubMed  Google Scholar 

Lossing TS, Kasper CK, Feinstein DI. Detection of factor VIII inhibitors with the partial thromboplastin time. Blood. 1977;49(5):793–7.

Article  CAS  PubMed  Google Scholar 

Hay CR, Brown S, Collins PW, Keeling DM, Liesner R. The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol. 2006;133(6):591–605.

Article  CAS  PubMed  Google Scholar 

Kershaw G, Orellana D. Mixing tests: diagnostic aides in the investigation of prolonged prothrombin times and activated partial thromboplastin times. Semin Thromb Hemost. 2013;39(3):283–90.

Article  CAS  PubMed  Google Scholar 

Chang SH, Tillema V, Scherr D. A “percent correction” formula for evaluation of mixing studies. Am J Clin Pathol. 2002;117(1):62–73.

Article  PubMed  Google Scholar 

Tang N, Chen Y, Li D, Yin S. Determining the cutoff value of the APTT mixing test for factor VIII inhibitor. Clin Chem Lab Med. 2019;57(5):e88–90.

Article  CAS  PubMed  Google Scholar 

Braun PJ, Givens TB, Stead AG, Beck LR, Gooch SA, Swan RJ, Fischer TJ. Properties of optical data from activated partial thromboplastin time and prothrombin time assays. Thromb Haemost. 1997;78(3):1079–87.

Article  CAS  PubMed  Google Scholar 

Shima M, Thachil J, Nair SC, Srivastava A, Scientific, Standardization C. Towards standardization of clot waveform analysis and recommendations for its clinical applications. J Thromb Haemost. 2013;11(7):1417–20.

Article  CAS  PubMed  Google Scholar 

Shima M, Matsumoto T, Fukuda K, Kubota Y, Tanaka I, Nishiya K, et al. The utility of activated partial thromboplastin time (aPTT) clot waveform analysis in the investigation of hemophilia A patients with very low levels of factor VIII activity (FVIII:C). Thromb Haemost. 2002;87(3):436–41.

Article  CAS  PubMed  Google Scholar 

Matsumoto T, Nogami K, Tabuchi Y, Yada K, Ogiwara K, Kurono H, et al. Clot waveform analysis using CS-2000i™ distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A. Haemophilia. 2017;23(5):e427–35.

Article  CAS  PubMed  Google Scholar 

Haku J, Nogami K, Matsumoto T, Ogiwara K, Shima M. Optimal monitoring of bypass therapy in hemophilia A patients with inhibitors by the use of clot waveform analysis. J Thromb Haemost. 2014;12(3):355–62.

Article  CAS  PubMed  Google Scholar 

Ochi S, Takeyama M, Shima M, Nogami K. Plasma-derived factors VIIa and X mixtures (Byclot ®) significantly improve impairment of coagulant potential ex vivo in plasmas from acquired hemophilia A patients. Int J Hematol. 2020;111(6):779–85.

Article  CAS  PubMed  Google Scholar 

Matsumoto T, Nogami K, Shima M. A combined approach using global coagulation assays quickly differentiates coagulation disorders with prolonged aPTT and low levels of FVIII activity. Int J Hematol. 2017;105:174–83.

Article  CAS  PubMed  Google Scholar 

Shimonishi N, Ogiwara K, Oda Y, Kawabe T, Emmi M, Shima M, Nogami K. Inhibitor index in the clot waveform analysis-based mixing test differentiates among hemophilia A without and with inhibitors, and lupus anticoagulant. Thromb Haemost. 2021;121(6):792–9.

Article  PubMed  Google Scholar 

Shimonishi N, Ogiwara K, Oda Y, Kawabe T, Okazaki S, Shima M, Nogami K. A novel assessment of factor VIII activity by template matching utilizing weighted average parameters from comprehensive clot waveform analysis. Thromb Haemost. 2021;121(2):164–73.

Article  PubMed  Google Scholar 

Rosner E, Pauzner R, Lusky A, Modan M, Many A. Detection and quantitative evaluation of lupus circulating anticoagulant activity. Thromb Haemost. 1987;57(2):144–7.

Article  CAS  PubMed  Google Scholar 

Moore GW, Culhane AP, Daw CR, Noronha CP, Kumano O. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant. Thromb Res. 2016;139:98–101.

Article  CAS  PubMed  Google Scholar 

Kumano O, Moore GW. Ruling out lupus anticoagulants with mixing test-specific cutoff assessment and the index of circulating anticoagulant. Res Pract Thromb Haemost. 2019;3(4):695–703.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu C, Ling L, Huang X, Mi J, Liao J, Jia J, et al. Evaluation of activated partial thromboplastin time mixing studies using several methods. Arch Pathol Lab Med. 2022;146(11):1387–94.

Article  CAS  PubMed  Google Scholar 

Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N, Suzuki T, Komiyama Y. New formulas for mixing test to discriminate between lupus anticoagulant and acquired hemophilia A. Thromb Res. 2016;143:53–7.

Article  CAS  PubMed  Google Scholar 

Pengo V, Tripodi A, Reber G, Rand JH, Ortel TL, Galli M, et al. Update of the guidelines for lupus anticoagulant detection. Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2009;7(10):1737–40.

Article  CAS  PubMed  Google Scholar 

Kumano O, Ieko M, Naito S, Yoshida M, Takahashi N. APTT reagent with ellagic acid as activator shows adequate lupus anticoagulant sensitivity in comparison to silica-based reagent. J Thromb Haemost. 2012;10(11):2338–43.

Article  CAS  PubMed  Google Scholar 

Dumoulin EN, Fiers L, Devreese KM. Investigation of sensitivity for coagulation factor deficiency in APTT and PT: how to perform it? Clin Chem Lab Med. 2016;54(5):e169–72.

Article  CAS  PubMed  Google Scholar 

Martinuzzo M, Barrera L, Rodriguez M, D’Adamo MA, Lopez MS, Otaso JC. Do PT and APTT sensitivities to factors’ deficiencies calculated by the H47–A2 2008 CLSI guideline reflect the deficiencies found in plasmas from patients? Int J Lab Hematol. 2015;37(6):853–60.

Article  CAS  PubMed  Google Scholar